Global Retirement Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
RCMNY
CP
Global Retirement Partners's ADMA Position: Q2 2026 in Review
Global Retirement Partners opened a new position in ADMA Biologics (ADMA) in Q2 2026: 330 shares worth $2.76K. The stake represents ﹤0.01% of the portfolio and ranks #3896 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ADMA as recently as Q4 2025.
Global Retirement Partners first reported a position in ADMA in Q3 2024 and has held it in 6 quarters since. The position peaked at $11.8K in Q2 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Global Retirement Partners held 330 shares of ADMA Biologics worth $2.76K as of Q2 2026.
- ADMA Biologics was a new Global Retirement Partners position in Q2 2026.
- ADMA Biologics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3896 holding.
- Global Retirement Partners first reported a position in ADMA Biologics in Q3 2024 and has held it in 6 quarters since.
- Global Retirement Partners's ADMA Biologics position peaked at $11.8K in Q2 2025.
- 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.